We have reported that the receptor for advanced glycation end product (RAGE) acts as a crucial surface marker on AECs, mediating a variety of inflammatory and cell damage responses, which are central to the pathogenesis of emphysema [18,19]. The gene discussed is AGER; the disease is pulmonary emphysema.